Roxado

Roxado uses and dosage

Roxado (ROXADUSTAT), generic EVRENZO is a prescription medicine used to treat adult patients with symptomatic anemia associated with chronic kidney disease (CKD). ROXADUSTAT is a first-in-class, orally administered HIF-PH inhibitor that promotes erythropoiesis through increasing endogenous production of erythropoietin, as well as improving iron regulation and overcoming the EPO-suppressive effects of inflammation on haemoglobin syntheses and red blood cell production by downregulating hepcidin. Roxado is manufactured by Ziska Pharma Ltd. in Bangladesh. ROXADUSTAT has to take orally 3 times per week with or without food and not on consecutive days.

Roxado side effects

The most common adverse reactions of ROXADUSTAT are: Hypertension, blood clot, diarrhea, peripheral edema, hyperkalaemia and nausea.

Originator brand

EVRENZO by Astellas

Made by

Ziska Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.